Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Strategic Expansion into AI-Powered Healthcare Solutions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  V.KHRN.W.H | KHRNF | KHRWF

Healthcare Cannabis
Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

Recent & Breaking News (TSXV:KHRN.H)

PharmaDrug Announces Execution Of an Agreement to Sell Its German Cannabis Asset to Khiron

Newsfile May 31, 2022

Khiron Life Sciences Reports First Quarter 2022 Financial Results with Record Revenue in Medical Cannabis

PR Newswire May 31, 2022

Khiron to Host First Quarter 2022 Conference Call on May 31, 2022

PR Newswire May 25, 2022

Khiron achieves United Kingdom Cannabis Sales Volume Growth of 240% in Q1 2022

PR Newswire May 10, 2022

Khiron Life Sciences Reports 2021 Fiscal Year End Results

PR Newswire May 2, 2022

Khiron to Host YE and Fourth Quarter 2021 Conference Call on May 2, 2022

PR Newswire April 27, 2022

Global Medical Cannabis Leader Khiron Opens New Zerenia(TM) Clinic and Retail Pharmacy in Colombia

PR Newswire April 11, 2022

LEADING GLOBAL MEDICAL CANNABIS COMPANY KHIRON PUBLISHES CLINICAL STUDY ON THE EFFECTIVENESS OF ITS PRODUCTS AT CONTROLLING CHRONIC PAIN

Canada NewsWire April 5, 2022

Medical Cannabis Innovator Khiron Continues to Disrupt Global Marketplace Signing Partnership with Teleton in Mexico

Canada NewsWire March 30, 2022

Khiron Life Sciences to Present at Upcoming March Investor Conferences

Canada NewsWire March 7, 2022

Khiron Life Sciences Corp to Webcast Live at VirtualInvestorConferences.com March 10th

GlobeNewswire March 7, 2022

Khiron Life Sciences Corp.: Invitation to the Q1 Virtual Investor Summit

Newsfile February 24, 2022

Khiron Adds Another Clinic Location in Peru

PR Newswire February 17, 2022

Khiron Opens New Medical Cannabis Clinic in Colombia

PR Newswire January 31, 2022

Mandatory Insurance Coverage for Medical Cannabis Now Expands to More than 50 million Colombians

PR Newswire January 4, 2022

Khiron to Participate in the Lytham Partners Winter 2021 Investor Conference

PR Newswire December 9, 2021

Khiron Announces Grants of Options and Restricted Share Units

PR Newswire November 23, 2021

Khiron Reports Q3 Results - Revenue Increased 83% YoY, 26% QoQ

PR Newswire November 22, 2021

Khiron to Host Third Quarter 2021 Conference Call on November 22, 2021

PR Newswire November 16, 2021

Khiron Life Sciences Corp.: Invitation to the Q4 Virtual Investor Summit

Newsfile November 9, 2021